Short-acting β<sub>2</sub>-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

2021103 citationsJournal Articlehybrid Open Access

Authors

Eric D. Bateman · University of Cape Town

David Price · University of Aberdeen

Hao‐Chien Wang · National Taiwan University Hospital

A. Khattab · Ain Shams University

Patricia Schonffeldt · Instituto Nacional del Tórax

Angelina Catanzariti · AstraZeneca (Australia)

Ralf J.P. van der Valk

Abstract

This study indicates an association between high SABA prescriptions and poor clinical outcomes across a broad range of countries, healthcare settings and asthma severities, providing support for initiatives to improve asthma morbidity by reducing SABA overreliance.

Topics & Keywords

Asthma and respiratory diseases Respiratory and Cough-Related Research Allergic Rhinitis and Sensitization

UN Sustainable Development Goals

No poverty

Publication Details

Published in: European Respiratory Journal

Volume 59, Issue 5, pp. 2101402-2101402

DOI: 10.1183/13993003.01402-2021

Field-Weighted Citation Impact: 9.84